0000000000564084

AUTHOR

E. Gómez

showing 2 related works from this author

SiPMs coated with TPB: coating protocol and characterization for NEXT

2012

[EN] Silicon photomultipliers (SiPM) are the photon detectors chosen for the tracking readout in NEXT, a neutrinoless \bb decay experiment which uses a high pressure gaseous xenon time projection chamber (TPC). The reconstruction of event track and topology in this gaseous detector is a key handle for background rejection. Among the commercially available sensors that can be used for tracking, SiPMs offer important advantages, mainly high gain, ruggedness, cost-effectiveness and radio-purity. Their main drawback, however, is their non sensitivity in the emission spectrum of the xenon scintillation (peak at 175 nm). This is overcome by coating these sensors with the organic wavelength shifte…

Materials sciencePhysics - Instrumentation and DetectorsFOS: Physical scienceschemistry.chemical_elementengineering.materialWavelength shifterTracking (particle physics)7. Clean energy01 natural sciencesHigh Energy Physics - ExperimentTECNOLOGIA ELECTRONICAHigh Energy Physics - Experiment (hep-ex)XenonSilicon photomultiplierCoating0103 physical sciencesSensitivity (control systems)Visible and IR photons (solid-state)010306 general physicsInstrumentationPhoton detectors for UVMathematical PhysicsScintillationTime projection chamber010308 nuclear & particles physicsbusiness.industryTime projection Chambers (TPC)FísicaDetectorsInstrumentation and Detectors (physics.ins-det)Gas detectorsScintillators scintillation and light emission processes (solid gas and liquid scintillators)Detectors de gasoschemistryParticle tracking detectors (Solid-state detectors)engineeringOptoelectronicsbusiness
researchProduct

Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a1

2019

Background: There have been few studies conducted on the efficacy and safety of specific immunotherapy with allergen extracts of fungi compared with other allergen extracts, and there are no data on the major allergen Alt a 1 of the fungus Alternaria alternata. Objectives: We sought to evaluate the efficacy and safety of subcutaneous immunotherapy with 2 different doses of Alt a 1 in patients with rhinoconjunctivitis caused by sensitization to A alternata. Method: We performed a multicenter, randomized, double-blind, placebo-controlled trial with Alt a 1 administered subcutaneously in patients with allergic rhinoconjunctivitis with or without controlled asthma aged 12 to 65 years. Three gro…

AdultMalesafetyAllergymedicine.medical_specialtyAllergen immunotherapyAl·lèrgiaAdolescentImmunologyefficacyPlacebo-controlled studyPlacebomedicine.disease_causeFungal ProteinsYoung AdultAllergenDouble-Blind Methodchildrensubcutaneous immunotherapyInternal medicinemedicineadultsImmunology and AllergyHumansmolecular immunotherapyAdverse effectChildAgedConjunctivitis AllergicAllergen immunotherapyIntention-to-treat analysisbusiness.industryrhinoconjunctivitisclinical trialAllergensImmunoglobulin EMiddle Agedmedicine.diseaseAsthmaClinical trialfungal allergyDesensitization ImmunologicImmunoglobulin GAlt a 1Femalebusinesspurified allergen
researchProduct